Thomas Sweeney Heard

Array ( [id] => 5379287 [patent_doc_number] => 20090191126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'PEPTIDE AND MULTIVALENT PEPTIDE CONJUGATE FOR DIAGNOSIS AND TREATMENT OF VASCULAR PLAQUES' [patent_app_type] => utility [patent_app_number] => 12/325110 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8164 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191126.pdf [firstpage_image] =>[orig_patent_app_number] => 12325110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580476 [patent_doc_number] => 20090175822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'C5-SUBSTITUTED, PROLINE-DERIVED, MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/324071 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18067 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175822.pdf [firstpage_image] =>[orig_patent_app_number] => 12324071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539666 [patent_doc_number] => 20090221471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'PRODRUGS OF VANCOMYCIN WITH HYDROLYSIS RESISTANT POLYMER LINKAGES' [patent_app_type] => utility [patent_app_number] => 12/275775 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8665 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221471.pdf [firstpage_image] =>[orig_patent_app_number] => 12275775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495225 [patent_doc_number] => 20100286056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'COMPOSITIONS FOR REDUCING OXIDATIVE STRESS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/742812 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6703 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286056.pdf [firstpage_image] =>[orig_patent_app_number] => 12742812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772404 [patent_doc_number] => 08426360 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Carbocyclic oxime hepatitis C virus serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/269941 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17375 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12269941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772403 [patent_doc_number] => 08426359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Inhibitors of serine proteases, particularly HCV NS3-NS4A protease' [patent_app_type] => utility [patent_app_number] => 12/265125 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22870 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12265125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552828 [patent_doc_number] => 20090286814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'HCV PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/264508 [patent_app_country] => US [patent_app_date] => 2008-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13070 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286814.pdf [firstpage_image] =>[orig_patent_app_number] => 12264508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675471 [patent_doc_number] => 08383583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/257769 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14750 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12257769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331280 [patent_doc_number] => 20090111757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'HCV PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/254439 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10807 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111757.pdf [firstpage_image] =>[orig_patent_app_number] => 12254439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552857 [patent_doc_number] => 20090286843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION' [patent_app_type] => utility [patent_app_number] => 12/254736 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122608 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286843.pdf [firstpage_image] =>[orig_patent_app_number] => 12254736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5928953 [patent_doc_number] => 20110038912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERY OF GLYCOPEPTIDE ANTIBIOTICS TO MEDICAL DEVICE SURFACES' [patent_app_type] => utility [patent_app_number] => 12/739353 [patent_app_country] => US [patent_app_date] => 2008-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17872 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038912.pdf [firstpage_image] =>[orig_patent_app_number] => 12739353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6492342 [patent_doc_number] => 20100093606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'MRSA Bactericidal Topical Gel' [patent_app_type] => utility [patent_app_number] => 12/236246 [patent_app_country] => US [patent_app_date] => 2008-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 243 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093606.pdf [firstpage_image] =>[orig_patent_app_number] => 12236246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506066 [patent_doc_number] => 20100210509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'LONG ACTING HYALURONIC ACID - PEPTIDE CONJUGATE' [patent_app_type] => utility [patent_app_number] => 12/680955 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6470 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210509.pdf [firstpage_image] =>[orig_patent_app_number] => 12680955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146696 [patent_doc_number] => 08163693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Urea-containing peptides as inhibitors of viral replication' [patent_app_type] => utility [patent_app_number] => 12/236855 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23018 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163693.pdf [firstpage_image] =>[orig_patent_app_number] => 12236855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340152 [patent_doc_number] => 08242077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Biosensor' [patent_app_type] => utility [patent_app_number] => 12/232393 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 8102 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12232393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326981 [patent_doc_number] => 20100197608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'USE OF MELANOTROPHIN-POTENTIATING FACTOR AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677585 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33163 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197608.pdf [firstpage_image] =>[orig_patent_app_number] => 12677585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535372 [patent_doc_number] => 20100204143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'GAMMA 1 MSH ALONE OR IN COMBINATION WITH PENTAGASTRIN AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677762 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35244 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204143.pdf [firstpage_image] =>[orig_patent_app_number] => 12677762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326928 [patent_doc_number] => 20100197600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'USE OF THE PEPTIDE HIS-SER-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE ALONE OR IN COMBINATION WITH THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS-OH AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/676904 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39082 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197600.pdf [firstpage_image] =>[orig_patent_app_number] => 12676904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326719 [patent_doc_number] => 20100197572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'USE OF SOMATOSTATIN-14 AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677813 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36282 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197572.pdf [firstpage_image] =>[orig_patent_app_number] => 12677813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326933 [patent_doc_number] => 20100197601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'USE OF A FIBRINOGEN RECEPTOR ANTAGONIST AND/OR FOLLICULAR GONADOTROPIN RELEASING PEPTIDE AS A THERAPEUTIC AGENT IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIA INFECTION' [patent_app_type] => utility [patent_app_number] => 12/676909 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36081 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197601.pdf [firstpage_image] =>[orig_patent_app_number] => 12676909 [rel_patent_id] =>[rel_patent_doc_number] =>)